Edwards Lifesciences (EW) Short Interest Ratio & Short Volume

$73.25 -1.46 (-1.95%)

Closing price 02/21/2025 03:59 PM Eastern

Extended Trading

$73.30 +0.05 (+0.07%)

As of 02/21/2025 06:00 PM Eastern

Edwards Lifesciences Short Interest Data

Edwards Lifesciences (EW) has a short interest of 10.05 million shares, representing 1.74% of the float (the number of shares available for trading by the public). This marks a 11.17% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 4.42 million shares to cover all short positions.

Current Short Interest: 10,050,000 shares
Previous Short Interest: 9,040,000 shares
Change Vs. Previous Month: +11.17%
Dollar Volume Sold Short: $727.69 million
Short Interest Ratio: 2.1 Days to Cover
Last Record Date: January 31, 2025

Outstanding Shares: 589,800,000 shares
Float Size: 576,370,000 shares
Short Percent of Float: 1.74%
Today's Trading Volume: 2,843,619 shares
Average Trading Volume: 4,417,774 shares
Today's Volume Vs. Average: 64%

Short Selling Edwards Lifesciences?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Edwards Lifesciences and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

EW Short Interest Over Time

EW Days to Cover Over Time

EW Percentage of Float Shorted Over Time

Edwards Lifesciences Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
1/31/2025	10,050,000 shares	$727.69 million	+11.2%	1.7%	2.1	$72.41
1/15/2025	9,040,000 shares	$635.42 million	-20.1%	1.6%	1.8	$70.29
12/31/2024	11,310,000 shares	$837.28 million	+54.9%	2.0%	2.2	$74.03
12/15/2024	7,300,000 shares	$535.24 million	-14.9%	1.3%	1.3	$73.32
11/30/2024	8,580,000 shares	$612.18 million	+24.9%	1.5%	1.5	$71.35
11/15/2024	6,870,000 shares	$465.51 million	-10.8%	1.2%	1.1	$67.76
10/31/2024	7,700,000 shares	$516.05 million	-6.3%	1.3%	1.3	$67.02
10/15/2024	8,220,000 shares	$566.36 million	-14.5%	1.4%	1.2	$68.90
9/30/2024	9,610,000 shares	$634.16 million	-15.6%	1.6%	1.4	$65.99
9/15/2024	11,380,000 shares	$779.76 million	+81.8%	1.9%	1.8	$68.52
Get the Latest News and Ratings for EW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Edwards Lifesciences and its competitors with MarketBeat's FREE daily newsletter.
8/31/2024	6,260,000 shares	$437.95 million	-1.3%	1.1%	1.1	$69.96
8/15/2024	6,340,000 shares	$432.01 million	+3.9%	1.1%	1.3	$68.14
7/31/2024	6,100,000 shares	$384.54 million	-20.8%	1.0%	1.4	$63.04
7/15/2024	7,700,000 shares	$689.15 million	-15.8%	1.3%	2.7	$89.50
6/30/2024	9,140,000 shares	$844.26 million	+11.6%	1.5%	3.3	$92.37
6/15/2024	8,190,000 shares	$714.91 million	-1.2%	1.4%	3	$87.29
5/31/2024	8,290,000 shares	$720.94 million	+3.6%	1.4%	2.9	$86.97
5/15/2024	8,000,000 shares	$721.28 million	-16.9%	1.4%	2.5	$90.16
4/30/2024	9,630,000 shares	$815.47 million	+30.5%	1.6%	2.7	$84.68
4/15/2024	7,380,000 shares	$658.30 million	-28.9%	1.3%	1.9	$89.20
3/31/2024	10,380,000 shares	$991.91 million	-0.7%	1.8%	2.6	$95.56
3/15/2024	10,450,000 shares	$964.64 million	+23.8%	1.8%	2.7	$92.31
2/29/2024	8,440,000 shares	$716.30 million	-16.4%	1.4%	1.9	$84.87
2/15/2024	10,090,000 shares	$868.35 million	+1.3%	1.7%	2.3	$86.06
1/31/2024	9,960,000 shares	$781.56 million	-8.4%	1.7%	2.2	$78.47
1/15/2024	10,870,000 shares	$804.71 million	+2.0%	1.8%	2.4	$74.03
12/31/2023	10,660,000 shares	$812.83 million	-21.3%	1.8%	2.3	$76.25
12/15/2023	13,540,000 shares	$1.04 billion	+34.7%	2.3%	2.8	$76.90
11/30/2023	10,050,000 shares	$680.49 million	-6.5%	1.7%	2.3	$67.71
11/15/2023	10,750,000 shares	$720.36 million	-6.3%	1.8%	2.6	$67.01
10/31/2023	11,470,000 shares	$730.87 million	-1.1%	1.9%	2.9	$63.72
10/15/2023	11,600,000 shares	$821.05 million	-13.4%	1.9%	3.1	$70.78
9/30/2023	13,400,000 shares	$928.35 million	+5.5%	2.2%	3.8	$69.28
9/15/2023	12,700,000 shares	$929.64 million	+18.1%	2.1%	4	$73.20
8/31/2023	10,750,000 shares	$822.05 million	+13.0%	1.8%	3.4	$76.47
8/15/2023	9,510,000 shares	$759.47 million	+0.4%	1.6%	3	$79.86
7/31/2023	9,470,000 shares	$777.20 million	-2.9%	1.6%	3.3	$82.07
7/15/2023	9,750,000 shares	$910.46 million	-0.9%	1.6%	3.7	$93.38
6/30/2023	9,840,000 shares	$928.21 million	-4.4%	1.6%	3.7	$94.33
6/15/2023	10,290,000 shares	$939.37 million	-7.4%	1.7%	3.8	$91.29
Collect $7k per month from Tesla’s SECRET dividend (Ad) There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works? Click here to uncover Tesla's hidden income secret.
5/31/2023	11,110,000 shares	$935.91 million	+12.9%	1.9%	3.9	$84.24
5/15/2023	9,840,000 shares	$874.97 million	+7.2%	1.6%	3.2	$88.92
4/30/2023	9,180,000 shares	$807.66 million	-27.3%	1.5%	2.8	$87.98
4/15/2023	12,620,000 shares	$1.06 billion	-10.1%	2.1%	3.6	$84.36
3/31/2023	14,040,000 shares	$1.16 billion	-17.1%	2.3%	4.1	$82.73
3/15/2023	16,940,000 shares	$1.35 billion	+32.7%	2.8%	4.7	$79.48
2/28/2023	12,770,000 shares	$1.03 billion	+6.8%	2.1%	3.2	$80.44
2/15/2023	11,960,000 shares	$931.92 million	-12.4%	2.0%	3	$77.92
1/31/2023	13,650,000 shares	$1.05 billion	-2.0%	2.2%	3	$76.70
1/15/2023	13,930,000 shares	$1.09 billion	-9.2%	2.3%	2.7	$78.31
12/30/2022	15,340,000 shares	$1.14 billion	+9.9%	2.5%	3	$74.61
12/15/2022	13,960,000 shares	$1.03 billion	+27.0%	2.3%	2.8	$73.55
11/30/2022	10,990,000 shares	$848.98 million	+4.0%	1.8%	2.3	$77.25
11/15/2022	10,570,000 shares	$802.90 million	+30.3%	1.7%	2.5	$75.96
10/31/2022	8,110,000 shares	$587.41 million	+8.9%	1.3%	2.2	$72.43
10/15/2022	7,450,000 shares	$614.03 million	-1.7%	1.2%	2.7	$82.42
9/30/2022	7,580,000 shares	$626.34 million	+15.9%	1.2%	3	$82.63
9/15/2022	6,540,000 shares	$620.52 million	+77.7%	1.1%	2.5	$94.88
8/31/2022	3,680,000 shares	$331.57 million	-27.0%	0.6%	1.4	$90.10
8/15/2022	5,040,000 shares	$527.89 million	-9.0%	0.8%	2	$104.74
7/31/2022	5,540,000 shares	$556.99 million	-16.8%	0.9%	2.1	$100.54
7/15/2022	6,660,000 shares	$662.20 million	+7.3%	1.1%	2.4	$99.43
6/30/2022	6,210,000 shares	$590.51 million	+5.8%	1.0%	2.2	$95.09
6/15/2022	5,870,000 shares	$521.14 million	-10.5%	2.9%	2	$88.78
5/31/2022	6,560,000 shares	$661.58 million	+27.4%	1.1%	2.3	$100.85
5/15/2022	5,150,000 shares	$502.38 million	+6.0%	0.8%	1.9	$97.55
4/30/2022	4,860,000 shares	$514.09 million	-15.2%	0.8%	1.8	$105.78
4/15/2022	5,730,000 shares	$687.71 million	+28.5%	0.9%	2.1	$120.02
3/31/2022	4,460,000 shares	$525.03 million	No Change	0.7%	1.7	$117.72
3/15/2022	4,460,000 shares	$473.43 million	-20.6%	0.7%	1.7	$106.15
2/28/2022	5,620,000 shares	$631.52 million	-11.1%	0.9%	2.1	$112.37
2/15/2022	6,320,000 shares	$701.08 million	+9.5%	1.0%	2.3	$110.93
1/31/2022	5,770,000 shares	$630.08 million	+6.5%	0.9%	2.2	$109.20
1/15/2022	5,420,000 shares	$640.97 million	-10.9%	0.9%	2.2	$118.26
12/31/2021	6,080,000 shares	$787.66 million	+10.0%	1.0%	2.6	$129.55
12/15/2021	5,530,000 shares	$663.10 million	-3.8%	0.9%	2.2	$119.91
11/30/2021	5,750,000 shares	$617.03 million	+4.0%	0.9%	2.5	$107.31
11/15/2021	5,530,000 shares	$645.30 million	-20.2%	0.9%	2.6	$116.69
10/29/2021	6,930,000 shares	$830.35 million	+6.0%	1.1%	3.3	$119.82
10/15/2021	6,540,000 shares	$733.53 million	+7.6%	1.1%	3.2	$112.16
9/30/2021	6,080,000 shares	$688.32 million	+2.7%	1.0%	2.8	$113.21
9/15/2021	5,920,000 shares	$716.44 million	-2.0%	1.0%	2.8	$121.02
8/31/2021	6,040,000 shares	$707.77 million	+0.8%	1.0%	2.8	$117.18
8/13/2021	5,990,000 shares	$677.77 million	-1.3%	1.0%	2.6	$113.15
7/30/2021	6,070,000 shares	$681.48 million	-8.9%	1.0%	2.6	$112.27
7/15/2021	6,660,000 shares	$708.22 million	+20.4%	1.1%	2.8	$106.34
6/30/2021	5,530,000 shares	$572.74 million	-9.1%	0.9%	2.2	$103.57
6/15/2021	6,080,000 shares	$609.70 million	+4.5%	1.0%	2.4	$100.28
5/28/2021	5,820,000 shares	$558.14 million	-2.8%	0.9%	2.3	$95.90
5/14/2021	5,990,000 shares	$526.76 million	-13.4%	N/A	2.2	$87.94
Collect $7k per month from Tesla’s SECRET dividend (Ad) There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works? Click here to uncover Tesla's hidden income secret.
4/30/2021	6,920,000 shares	$666.12 million	+5.2%	N/A	2.5	$96.26
4/15/2021	6,580,000 shares	$567.53 million	+24.6%	N/A	2.3	$86.25
3/31/2021	5,280,000 shares	$437.45 million	-2.6%	N/A	2	$82.85
3/15/2021	5,420,000 shares	$444.82 million	-3.0%	N/A	2.1	$82.07
2/26/2021	5,590,000 shares	$469.39 million	-17.1%	N/A	2.2	$83.97
2/12/2021	6,740,000 shares	$593.59 million	+50.8%	N/A	2.8	$88.07
1/29/2021	4,470,000 shares	$372.71 million	+3.5%	N/A	1.8	$83.38
1/15/2021	4,320,000 shares	$377.96 million	-6.9%	N/A	1.7	$87.49
12/31/2020	4,640,000 shares	$415.93 million	-5.7%	N/A	1.9	$89.64
12/15/2020	4,920,000 shares	$411.16 million	-7.5%	N/A	2	$83.57
11/30/2020	5,320,000 shares	$453.58 million	+6.0%	N/A	2.1	$85.26
11/15/2020	5,020,000 shares	$410.54 million	+0.8%	N/A	1.9	$81.78
10/30/2020	4,980,000 shares	$363.09 million	-29.7%	N/A	2	$72.91
10/15/2020	7,080,000 shares	$603.00 million	+5.8%	N/A	3	$85.17
9/30/2020	6,690,000 shares	$534.00 million	-2.8%	N/A	2.6	$79.82
9/15/2020	6,880,000 shares	$573.10 million	-5.0%	N/A	2.6	$83.30
8/31/2020	7,240,000 shares	$621.48 million	+15.7%	N/A	2.7	$85.84
8/14/2020	6,260,000 shares	$488.72 million	-3.4%	N/A	2.2	$78.07
7/31/2020	6,480,000 shares	$508.10 million	-12.0%	N/A	2.2	$78.41
7/15/2020	7,360,000 shares	$524.18 million	-7.1%	N/A	2.3	$71.22
6/30/2020	7,920,000 shares	$537.69 million	+8.9%	N/A	2.4	$67.89
6/15/2020	7,270,000 shares	$501.34 million	+206.8%	N/A	1.9	$68.96
5/29/2020	2,370,000 shares	$532.59 million	-4.1%	N/A	0.5	$224.72
5/15/2020	2,470,000 shares	$175.34 million	+3.8%	1.2%	1.5	$70.99
4/30/2020	2,380,000 shares	$172.55 million	-4.0%	1.2%	1.4	$72.50
4/15/2020	2,480,000 shares	$177.44 million	-18.7%	1.2%	1.4	$71.55
3/31/2020	3,050,000 shares	$681.61 million	+31.3%	1.5%	1.7	$223.48
3/13/2020	2,322,900 shares	$500.45 million	+7.5%	1.1%	1.6	$215.44
2/28/2020	2,160,000 shares	$339.62 million	+4.4%	1.0%	1.4	$157.23

EW Short Interest - Frequently Asked Questions

What is Edwards Lifesciences' current short interest?: Short interest is the volume of Edwards Lifesciences shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 10,050,000 shares of EW short. 1.74% of Edwards Lifesciences' shares are currently sold short. Learn More on Edwards Lifesciences' current short interest.
What is a good short interest ratio for Edwards Lifesciences?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EW shares currently have a short interest ratio of 2.0. Learn More on Edwards Lifesciences's short interest ratio.
Which institutional investors are shorting Edwards Lifesciences?: As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edwards Lifesciences: Wolverine Trading LLC, Squarepoint Ops LLC, Millennium Management LLC, Jefferies Financial Group Inc., Group One Trading LLC, Eisler Capital Management Ltd., Cubist Systematic Strategies LLC, Caption Management LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Bank of America Corp DE, Jane Street Group LLC, Paloma Partners Management Co, TIG Advisors LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, Hsbc Holdings PLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., JPMorgan Chase & Co., Twin Tree Management LP, Garda Capital Partners LP, Allianz Asset Management GmbH, Genus Capital Management Inc., IMC Chicago LLC, Caas Capital Management LP, Baader Bank Aktiengesellschaft, SG Americas Securities LLC, Wealth Enhancement Advisory Services LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.
What is a good short interest percentage for Edwards Lifesciences?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.74% of Edwards Lifesciences' floating shares are currently sold short.
Is Edwards Lifesciences' short interest increasing or decreasing?: Edwards Lifesciences saw a increase in short interest in January. As of January 31st, there was short interest totaling 10,050,000 shares, an increase of 11.2% from the previous total of 9,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is Edwards Lifesciences' float size?: Edwards Lifesciences currently has issued a total of 589,800,000 shares. Some of Edwards Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edwards Lifesciences currently has a public float of 576,370,000 shares.

How does Edwards Lifesciences' short interest compare to its competitors?: 1.74% of Edwards Lifesciences' shares are currently sold short. Here is how the short interest of companies compare to Edwards Lifesciences: Boston Scientific Co. (0.71%), Stryker Co. (1.11%), Medtronic plc (1.10%), Becton, Dickinson and Company (0.94%), IDEXX Laboratories, Inc. (2.42%), DexCom, Inc. (2.52%), ResMed Inc. (5.65%), STERIS plc (1.02%), Insulet Co. (3.48%), Baxter International Inc. (3.42%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.
What does it mean to sell short Edwards Lifesciences stock?: Short selling EW is an investing strategy that aims to generate trading profit from Edwards Lifesciences as its price is falling. EW shares are trading down $1.46 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Edwards Lifesciences?: A short squeeze for Edwards Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EW, which in turn drives the price of the stock up even further.
How often is Edwards Lifesciences' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EW, twice per month. The most recent reporting period available is January, 31 2025.

More Short Interest Resources from MarketBeat

Related Companies

Short Interest Tools

This page (NYSE:EW) was last updated on 2/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edwards Lifesciences (EW) Short Interest Ratio & Short Volume